EBS
HealthcareEmergent BioSolutions Inc.
$8.07-0.06 (-0.74%)
Prev Close
$8.13
Open
$8.23
High
$8.44
Low
$8.01
Volume
397.3K
Market Cap
$442.0M
P/E
8.77
Div Yield
—
Over the past 12 months, insider activity at Emergent BioSolutions Inc. (EBS) has been dominated by selling, with 1 insider purchase totaling $349.8K and 22 insider sales totaling $2.42M. The most recent insider transaction was by Perl Jessica (SVP, General Counsel, Corp Sec), who sold $10.1K worth of shares on Feb 9, 2026. Emergent BioSolutions Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry, with a market cap of $442.0M.
Buys (12M)
1
$349.8K
Sells (12M)
22
$2.42M
Net Activity
Net Seller
$2.07M
Active Insiders
12
last 12 mo
EBS Price Chart
EBS Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 9, 2026↗ | Perl Jessica | SVP, General Counsel, Corp Sec | Sell | 918 | $11.03 | $10.1K | 0 |
| Feb 6, 2026↗ | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 31,699 | $10.92 | $346.2K | 0 |
| Feb 6, 2026↗ | Hartzel William | SVP, Bioservices | Sell | 6,401 | $10.92 | $69.9K | 0 |
| Feb 6, 2026↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 51,797 | $10.92 | $565.6K | 0 |
| Feb 6, 2026↗ | Williams Paul Anthony | SVP, Products Business | Sell | 9,677 | $10.92 | $105.7K | 0 |
| Dec 14, 2025↗ | Lowry Simon C | SVP, R&D, CMO | Sell | 3,543 | $11.41 | $40.4K | 0 |
| Dec 5, 2025↗ | Richard Ronald | Director | Sell | 32,848 | $11.94 | $392.3K | 0 |
| Nov 11, 2025↗ | Hartzel William | SVP, Bioservices | Sell | 610 | $10.88 | $6.6K | 0 |
| Nov 10, 2025↗ | DeGolyer Donald W | Director | Sell | 17,801 | $10.54 | $187.6K | 0 |
| Nov 7, 2025↗ | Dayal Sujata Tyagi | Director | Sell | 8,552 | $10.00 | $85.5K | 0 |
| Oct 15, 2025↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 4,995 | $9.60 | $48.0K | 0 |
| Oct 7, 2025↗ | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 30,608 | $10.00 | $306.1K | 0 |
| Aug 15, 2025↗ | Zoon Kathryn C | Director | Sell | 7,086 | $8.87 | $62.9K | 0 |
| Aug 12, 2025↗ | DeGolyer Donald W | Director | Sell | 7,844 | $8.65 | $67.8K | 0 |
| Jul 11, 2025↗ | Hartzel William | SVP, Bioservices | Sell | 4,263 | $7.36 | $31.4K | 0 |
| Jun 8, 2025↗ | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 1,249 | $6.63 | $8.3K | 0 |
| Jun 8, 2025↗ | Hartzel William | SVP, Bioservices | Sell | 1,167 | $6.63 | $7.7K | 0 |
| Jun 8, 2025↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 2,733 | $6.63 | $18.1K | 0 |
| Jun 8, 2025↗ | Williams Paul Anthony | SVP, Products Business | Sell | 464 | $6.63 | $3.1K | 0 |
| May 23, 2025↗ | Katkin Keith | Director | Sell | 7,844 | $6.30 | $49.4K | 0 |
| May 13, 2025↗ | PAPA JOSEPH C | President and CEO | Buy | 60,000 | $5.83 | $349.8K | 0 |
| Apr 7, 2025↗ | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 480 | $4.44 | $2.1K | 0 |
| Apr 7, 2025↗ | Hartzel William | SVP, Bioservices | Sell | 561 | $4.44 | $2.5K | 0 |
| Mar 12, 2025↗ | Fowler Neal Franklin | Director | Sell | 35,000 | $5.83 | $204.1K | 0 |
| Mar 12, 2025↗ | Zoon Kathryn C | Director | Sell | 10,000 | $5.73 | $57.3K | 0 |
| Mar 5, 2025↗ | Hartzel William | SVP, Bioservices | Sell | 292 | $5.80 | $1.7K | 0 |
| Feb 28, 2025↗ | Williams Paul Anthony | SVP, Products Business | Sell | 498 | $7.48 | $3.7K | 0 |
| Feb 12, 2025↗ | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 313 | $7.48 | $2.3K | 0 |
| Feb 12, 2025↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 1,756 | $7.48 | $13.1K | 0 |
| Feb 9, 2025↗ | Perl Jessica | SVP, General Counsel, Corp Sec | Sell | 918 | $10.00 | $9.2K | 0 |
| Dec 8, 2024↗ | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 18,674 | $9.01 | $168.3K | 0 |
| Nov 12, 2024↗ | DeGolyer Donald W | Director | Sell | 25,000 | $10.91 | $272.8K | 0 |
| Nov 11, 2024↗ | Hartzel William | SVP, Bioservices | Sell | 632 | $11.97 | $7.6K | 0 |
| Nov 11, 2024↗ | White Marvin L | Director | Sell | 14,287 | $11.97 | $171.0K | 0 |
| Jul 8, 2024↗ | Williams Paul Anthony | SVP, Products Business | Sell | 85 | $8.13 | $691.05 | 0 |
| Jun 8, 2024↗ | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | Sell | 2,376 | $6.19 | $14.7K | 0 |
| Jun 8, 2024↗ | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 1,249 | $6.19 | $7.7K | 0 |
| Jun 8, 2024↗ | Hartzel William | SVP, Bioservices | Sell | 1,167 | $6.19 | $7.2K | 0 |
| Jun 8, 2024↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 2,733 | $6.19 | $16.9K | 0 |
| Jun 8, 2024↗ | Williams Paul Anthony | SVP, Products Business | Sell | 464 | $6.19 | $2.9K | 0 |
| Jun 4, 2024↗ | Zoon Kathryn C | Director | Sell | 10,000 | $6.11 | $61.1K | 0 |
| May 29, 2024↗ | Zoon Kathryn C | Director | Sell | 1,830 | $4.61 | $8.4K | 0 |
| May 21, 2024↗ | Zoon Kathryn C | Director | Sell | 1,089 | $5.78 | $6.3K | 0 |
| Apr 7, 2024↗ | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 585 | $2.29 | $1.3K | 0 |
| Apr 7, 2024↗ | Hartzel William | SVP, Bioservices | Sell | 665 | $2.29 | $1.5K | 0 |
| Mar 5, 2024↗ | Hartzel William | SVP, Bioservices | Sell | 346 | $3.41 | $1.2K | 0 |
| Mar 1, 2024↗ | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 381 | $3.39 | $1.3K | 0 |
| Feb 29, 2024↗ | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | Sell | 4,806 | $3.25 | $15.6K | 0 |
| Feb 29, 2024↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 9,721 | $3.24 | $31.5K | 0 |
| Feb 29, 2024↗ | Williams Paul Anthony | SVP, Products Business | Sell | 587 | $3.27 | $1.9K | 0 |
| Feb 23, 2024↗ | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | Sell | 229 | $2.74 | $627.46 | 0 |
| Feb 23, 2024↗ | Williams Paul Anthony | SVP, Products Business | Sell | 105 | $2.74 | $287.70 | 0 |
| Feb 21, 2024↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 4,529 | $2.71 | $12.3K | 0 |
| Nov 13, 2023↗ | Williams Paul Anthony | SVP, Products Business | Sell | 566 | $1.82 | $1.0K | 0 |
| Nov 11, 2023↗ | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | Sell | 413 | $2.00 | $826.00 | 0 |
| Nov 11, 2023↗ | Hartzel William | SVP, Bioservices | Sell | 632 | $2.00 | $1.3K | 0 |
| May 25, 2023↗ | Zoon Kathryn C | Director | Sell | 3,530 | $8.36 | $29.5K | 0 |
| Feb 28, 2023↗ | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | Sell | 1,005 | $12.38 | $12.4K | 0 |
| Feb 28, 2023↗ | Havey Adam | EVP, Business Operations | Sell | 998 | $12.38 | $12.4K | 0 |
| Feb 28, 2023↗ | Kramer Robert | President and CEO | Sell | 3,226 | $12.38 | $39.9K | 0 |
| Feb 28, 2023↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 1,074 | $12.38 | $13.3K | 0 |
| Feb 28, 2023↗ | SARAN ATUL | EVP, Chief Strat & Dev Officer | Sell | 971 | $12.38 | $12.0K | 0 |
| Feb 28, 2023↗ | Strei Katherine | EVP, Chief HR Officer | Sell | 690 | $12.38 | $8.5K | 0 |
| Feb 28, 2023↗ | Williams Paul Anthony | SVP, Products Business | Sell | 371 | $12.38 | $4.6K | 0 |
| Feb 23, 2023↗ | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | Sell | 489 | $13.99 | $6.8K | 0 |
| Feb 23, 2023↗ | Havey Adam | EVP, Business Operations | Sell | 1,244 | $13.91 | $17.3K | 0 |
| Feb 23, 2023↗ | Kramer Robert | President and CEO | Sell | 3,019 | $13.99 | $42.2K | 0 |
| Feb 23, 2023↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 1,421 | $13.89 | $19.7K | 0 |
| Feb 23, 2023↗ | SARAN ATUL | EVP, Chief Strat & Dev Officer | Sell | 1,210 | $13.89 | $16.8K | 0 |
| Feb 23, 2023↗ | Strei Katherine | EVP, Chief HR Officer | Sell | 1,006 | $13.92 | $14.0K | 0 |
| Feb 23, 2023↗ | Williams Paul Anthony | SVP, Products Business | Sell | 89 | $14.30 | $1.3K | 0 |
| Feb 8, 2023↗ | Havey Adam | EVP, Business Operations | Sell | 1,964 | $13.25 | $26.0K | 0 |
| Feb 8, 2023↗ | Kramer Robert | President and CEO | Sell | 4,944 | $13.25 | $65.5K | 0 |
| Feb 8, 2023↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 2,396 | $13.25 | $31.7K | 0 |
| Feb 8, 2023↗ | SARAN ATUL | EVP, Chief Strat & Dev Officer | Sell | 2,051 | $13.25 | $27.2K | 0 |
| Feb 8, 2023↗ | Strei Katherine | EVP, Chief HR Officer | Sell | 1,438 | $13.25 | $19.1K | 0 |
| Nov 25, 2022↗ | Richard Ronald | Director | Sell | 1,912 | $11.94 | $22.8K | 0 |
| Nov 11, 2022↗ | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | Sell | 416 | $15.00 | $6.2K | 0 |
| Jun 9, 2022↗ | Zoon Kathryn C | Director | Sell | 1,173 | $31.52 | $37.0K | 0 |
| May 24, 2022↗ | Zoon Kathryn C | Director | Sell | 1,996 | $35.53 | $70.9K | 0 |
| Feb 28, 2022↗ | Havey Adam | EVP, Business Operations | Sell | 739 | $39.64 | $29.3K | 0 |
| Feb 28, 2022↗ | Kramer Robert | President and CEO | Sell | 1,715 | $39.64 | $68.0K | 0 |
| Feb 28, 2022↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 818 | $39.64 | $32.4K | 0 |
| Feb 28, 2022↗ | SARAN ATUL | EVP, Chief Strat & Dev Officer | Sell | 764 | $39.64 | $30.3K | 0 |
| Feb 28, 2022↗ | Strei Katherine | EVP, Chief HR Officer | Sell | 561 | $39.64 | $22.2K | 0 |
| Feb 23, 2022↗ | Havey Adam | EVP, Business Operations | Sell | 1,252 | $42.39 | $53.1K | 0 |
| Feb 23, 2022↗ | Kramer Robert | President and CEO | Sell | 3,453 | $42.37 | $146.3K | 0 |
| Feb 23, 2022↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 1,499 | $42.39 | $63.5K | 0 |
| Feb 23, 2022↗ | SARAN ATUL | EVP, Corp Dev, GC & Secretary | Sell | 1,299 | $42.39 | $55.1K | 0 |
| Feb 23, 2022↗ | Strei Katherine | EVP, Chief HR Officer | Sell | 934 | $42.38 | $39.6K | 0 |
| Feb 22, 2022↗ | Havey Adam | EVP, Business Operations | Sell | 1,980 | $42.23 | $83.6K | 0 |
| Feb 22, 2022↗ | Kramer Robert | President and CEO | Sell | 4,595 | $42.23 | $194.0K | 0 |
| Feb 22, 2022↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 2,298 | $42.23 | $97.0K | 0 |
| Feb 22, 2022↗ | SARAN ATUL | EVP, Corp Dev, GC & Secretary | Sell | 2,084 | $42.23 | $88.0K | 0 |
| Feb 22, 2022↗ | Strei Katherine | EVP, Chief HR Officer | Sell | 1,616 | $42.23 | $68.2K | 0 |
| Nov 15, 2021↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Buy | 3,000 | $37.46 | $112.4K | 0 |
| May 25, 2021↗ | Zoon Kathryn C | Director | Sell | 3,139 | $56.48 | $177.3K | 0 |
| May 10, 2021↗ | SULLIVAN LOUIS W | Director | Sell | 3,118 | $61.62 | $192.1K | 0 |
| May 8, 2021↗ | Kramer Robert | President and CEO | Sell | 94 | $61.62 | $5.8K | 0 |
| May 8, 2021↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 1,054 | $61.62 | $64.9K | 0 |
| May 7, 2021↗ | Smith Karen L. | EVP, Chief Medical Officer | Sell | 305 | $60.85 | $18.6K | 0 |
| Mar 4, 2021↗ | Bailey Sue | Director | Sell | 8,168 | $92.37 | $754.5K | 0 |
| Mar 1, 2021↗ | Havey Adam | EVP, Business Operations | Sell | 37,279 | $99.30 | $3.70M | 0 |
| Feb 24, 2021↗ | Havey Adam | EVP, Business Operations | Sell | 2,318 | $95.81 | $222.1K | 0 |
| Feb 24, 2021↗ | Kramer Robert | President and CEO | Sell | 5,001 | $95.38 | $477.0K | 0 |
| Feb 24, 2021↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 1,829 | $95.13 | $174.0K | 0 |
| Feb 24, 2021↗ | SARAN ATUL | EVP, Corp Dev, GC & Secretary | Sell | 2,450 | $95.82 | $234.8K | 0 |
| Feb 24, 2021↗ | Strei Katherine | EVP, Chief HR Officer | Sell | 1,829 | $95.91 | $175.4K | 0 |
EBS Insider Buying Activity
The following table shows recent insider purchases of Emergent BioSolutions Inc. (EBS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 13, 2025↗ | PAPA JOSEPH C | President and CEO | Buy | 60,000 | $5.83 | $349.8K | 0 |
| Nov 15, 2021↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Buy | 3,000 | $37.46 | $112.4K | 0 |
EBS Insider Selling Activity
The following table shows recent insider sales of Emergent BioSolutions Inc. (EBS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 9, 2026↗ | Perl Jessica | SVP, General Counsel, Corp Sec | Sell | 918 | $11.03 | $10.1K | 0 |
| Feb 6, 2026↗ | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 31,699 | $10.92 | $346.2K | 0 |
| Feb 6, 2026↗ | Hartzel William | SVP, Bioservices | Sell | 6,401 | $10.92 | $69.9K | 0 |
| Feb 6, 2026↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 51,797 | $10.92 | $565.6K | 0 |
| Feb 6, 2026↗ | Williams Paul Anthony | SVP, Products Business | Sell | 9,677 | $10.92 | $105.7K | 0 |
| Dec 14, 2025↗ | Lowry Simon C | SVP, R&D, CMO | Sell | 3,543 | $11.41 | $40.4K | 0 |
| Dec 5, 2025↗ | Richard Ronald | Director | Sell | 32,848 | $11.94 | $392.3K | 0 |
| Nov 11, 2025↗ | Hartzel William | SVP, Bioservices | Sell | 610 | $10.88 | $6.6K | 0 |
| Nov 10, 2025↗ | DeGolyer Donald W | Director | Sell | 17,801 | $10.54 | $187.6K | 0 |
| Nov 7, 2025↗ | Dayal Sujata Tyagi | Director | Sell | 8,552 | $10.00 | $85.5K | 0 |
| Oct 15, 2025↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 4,995 | $9.60 | $48.0K | 0 |
| Oct 7, 2025↗ | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 30,608 | $10.00 | $306.1K | 0 |
| Aug 15, 2025↗ | Zoon Kathryn C | Director | Sell | 7,086 | $8.87 | $62.9K | 0 |
| Aug 12, 2025↗ | DeGolyer Donald W | Director | Sell | 7,844 | $8.65 | $67.8K | 0 |
| Jul 11, 2025↗ | Hartzel William | SVP, Bioservices | Sell | 4,263 | $7.36 | $31.4K | 0 |
| Jun 8, 2025↗ | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 1,249 | $6.63 | $8.3K | 0 |
| Jun 8, 2025↗ | Hartzel William | SVP, Bioservices | Sell | 1,167 | $6.63 | $7.7K | 0 |
| Jun 8, 2025↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 2,733 | $6.63 | $18.1K | 0 |
| Jun 8, 2025↗ | Williams Paul Anthony | SVP, Products Business | Sell | 464 | $6.63 | $3.1K | 0 |
| May 23, 2025↗ | Katkin Keith | Director | Sell | 7,844 | $6.30 | $49.4K | 0 |
| Apr 7, 2025↗ | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 480 | $4.44 | $2.1K | 0 |
| Apr 7, 2025↗ | Hartzel William | SVP, Bioservices | Sell | 561 | $4.44 | $2.5K | 0 |
| Mar 12, 2025↗ | Fowler Neal Franklin | Director | Sell | 35,000 | $5.83 | $204.1K | 0 |
| Mar 12, 2025↗ | Zoon Kathryn C | Director | Sell | 10,000 | $5.73 | $57.3K | 0 |
| Mar 5, 2025↗ | Hartzel William | SVP, Bioservices | Sell | 292 | $5.80 | $1.7K | 0 |
| Feb 28, 2025↗ | Williams Paul Anthony | SVP, Products Business | Sell | 498 | $7.48 | $3.7K | 0 |
| Feb 12, 2025↗ | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 313 | $7.48 | $2.3K | 0 |
| Feb 12, 2025↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 1,756 | $7.48 | $13.1K | 0 |
| Feb 9, 2025↗ | Perl Jessica | SVP, General Counsel, Corp Sec | Sell | 918 | $10.00 | $9.2K | 0 |
| Dec 8, 2024↗ | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 18,674 | $9.01 | $168.3K | 0 |
| Nov 12, 2024↗ | DeGolyer Donald W | Director | Sell | 25,000 | $10.91 | $272.8K | 0 |
| Nov 11, 2024↗ | Hartzel William | SVP, Bioservices | Sell | 632 | $11.97 | $7.6K | 0 |
| Nov 11, 2024↗ | White Marvin L | Director | Sell | 14,287 | $11.97 | $171.0K | 0 |
| Jul 8, 2024↗ | Williams Paul Anthony | SVP, Products Business | Sell | 85 | $8.13 | $691.05 | 0 |
| Jun 8, 2024↗ | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | Sell | 2,376 | $6.19 | $14.7K | 0 |
| Jun 8, 2024↗ | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 1,249 | $6.19 | $7.7K | 0 |
| Jun 8, 2024↗ | Hartzel William | SVP, Bioservices | Sell | 1,167 | $6.19 | $7.2K | 0 |
| Jun 8, 2024↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 2,733 | $6.19 | $16.9K | 0 |
| Jun 8, 2024↗ | Williams Paul Anthony | SVP, Products Business | Sell | 464 | $6.19 | $2.9K | 0 |
| Jun 4, 2024↗ | Zoon Kathryn C | Director | Sell | 10,000 | $6.11 | $61.1K | 0 |
| May 29, 2024↗ | Zoon Kathryn C | Director | Sell | 1,830 | $4.61 | $8.4K | 0 |
| May 21, 2024↗ | Zoon Kathryn C | Director | Sell | 1,089 | $5.78 | $6.3K | 0 |
| Apr 7, 2024↗ | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 585 | $2.29 | $1.3K | 0 |
| Apr 7, 2024↗ | Hartzel William | SVP, Bioservices | Sell | 665 | $2.29 | $1.5K | 0 |
| Mar 5, 2024↗ | Hartzel William | SVP, Bioservices | Sell | 346 | $3.41 | $1.2K | 0 |
| Mar 1, 2024↗ | Glessner Coleen | EVP, Quality & Ethics, and CPL | Sell | 381 | $3.39 | $1.3K | 0 |
| Feb 29, 2024↗ | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | Sell | 4,806 | $3.25 | $15.6K | 0 |
| Feb 29, 2024↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 9,721 | $3.24 | $31.5K | 0 |
| Feb 29, 2024↗ | Williams Paul Anthony | SVP, Products Business | Sell | 587 | $3.27 | $1.9K | 0 |
| Feb 23, 2024↗ | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | Sell | 229 | $2.74 | $627.46 | 0 |
| Feb 23, 2024↗ | Williams Paul Anthony | SVP, Products Business | Sell | 105 | $2.74 | $287.70 | 0 |
| Feb 21, 2024↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 4,529 | $2.71 | $12.3K | 0 |
| Nov 13, 2023↗ | Williams Paul Anthony | SVP, Products Business | Sell | 566 | $1.82 | $1.0K | 0 |
| Nov 11, 2023↗ | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | Sell | 413 | $2.00 | $826.00 | 0 |
| Nov 11, 2023↗ | Hartzel William | SVP, Bioservices | Sell | 632 | $2.00 | $1.3K | 0 |
| May 25, 2023↗ | Zoon Kathryn C | Director | Sell | 3,530 | $8.36 | $29.5K | 0 |
| Feb 28, 2023↗ | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | Sell | 1,005 | $12.38 | $12.4K | 0 |
| Feb 28, 2023↗ | Havey Adam | EVP, Business Operations | Sell | 998 | $12.38 | $12.4K | 0 |
| Feb 28, 2023↗ | Kramer Robert | President and CEO | Sell | 3,226 | $12.38 | $39.9K | 0 |
| Feb 28, 2023↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 1,074 | $12.38 | $13.3K | 0 |
| Feb 28, 2023↗ | SARAN ATUL | EVP, Chief Strat & Dev Officer | Sell | 971 | $12.38 | $12.0K | 0 |
| Feb 28, 2023↗ | Strei Katherine | EVP, Chief HR Officer | Sell | 690 | $12.38 | $8.5K | 0 |
| Feb 28, 2023↗ | Williams Paul Anthony | SVP, Products Business | Sell | 371 | $12.38 | $4.6K | 0 |
| Feb 23, 2023↗ | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | Sell | 489 | $13.99 | $6.8K | 0 |
| Feb 23, 2023↗ | Havey Adam | EVP, Business Operations | Sell | 1,244 | $13.91 | $17.3K | 0 |
| Feb 23, 2023↗ | Kramer Robert | President and CEO | Sell | 3,019 | $13.99 | $42.2K | 0 |
| Feb 23, 2023↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 1,421 | $13.89 | $19.7K | 0 |
| Feb 23, 2023↗ | SARAN ATUL | EVP, Chief Strat & Dev Officer | Sell | 1,210 | $13.89 | $16.8K | 0 |
| Feb 23, 2023↗ | Strei Katherine | EVP, Chief HR Officer | Sell | 1,006 | $13.92 | $14.0K | 0 |
| Feb 23, 2023↗ | Williams Paul Anthony | SVP, Products Business | Sell | 89 | $14.30 | $1.3K | 0 |
| Feb 8, 2023↗ | Havey Adam | EVP, Business Operations | Sell | 1,964 | $13.25 | $26.0K | 0 |
| Feb 8, 2023↗ | Kramer Robert | President and CEO | Sell | 4,944 | $13.25 | $65.5K | 0 |
| Feb 8, 2023↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 2,396 | $13.25 | $31.7K | 0 |
| Feb 8, 2023↗ | SARAN ATUL | EVP, Chief Strat & Dev Officer | Sell | 2,051 | $13.25 | $27.2K | 0 |
| Feb 8, 2023↗ | Strei Katherine | EVP, Chief HR Officer | Sell | 1,438 | $13.25 | $19.1K | 0 |
| Nov 25, 2022↗ | Richard Ronald | Director | Sell | 1,912 | $11.94 | $22.8K | 0 |
| Nov 11, 2022↗ | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | Sell | 416 | $15.00 | $6.2K | 0 |
| Jun 9, 2022↗ | Zoon Kathryn C | Director | Sell | 1,173 | $31.52 | $37.0K | 0 |
| May 24, 2022↗ | Zoon Kathryn C | Director | Sell | 1,996 | $35.53 | $70.9K | 0 |
| Feb 28, 2022↗ | Havey Adam | EVP, Business Operations | Sell | 739 | $39.64 | $29.3K | 0 |
| Feb 28, 2022↗ | Kramer Robert | President and CEO | Sell | 1,715 | $39.64 | $68.0K | 0 |
| Feb 28, 2022↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 818 | $39.64 | $32.4K | 0 |
| Feb 28, 2022↗ | SARAN ATUL | EVP, Chief Strat & Dev Officer | Sell | 764 | $39.64 | $30.3K | 0 |
| Feb 28, 2022↗ | Strei Katherine | EVP, Chief HR Officer | Sell | 561 | $39.64 | $22.2K | 0 |
| Feb 23, 2022↗ | Havey Adam | EVP, Business Operations | Sell | 1,252 | $42.39 | $53.1K | 0 |
| Feb 23, 2022↗ | Kramer Robert | President and CEO | Sell | 3,453 | $42.37 | $146.3K | 0 |
| Feb 23, 2022↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 1,499 | $42.39 | $63.5K | 0 |
| Feb 23, 2022↗ | SARAN ATUL | EVP, Corp Dev, GC & Secretary | Sell | 1,299 | $42.39 | $55.1K | 0 |
| Feb 23, 2022↗ | Strei Katherine | EVP, Chief HR Officer | Sell | 934 | $42.38 | $39.6K | 0 |
| Feb 22, 2022↗ | Havey Adam | EVP, Business Operations | Sell | 1,980 | $42.23 | $83.6K | 0 |
| Feb 22, 2022↗ | Kramer Robert | President and CEO | Sell | 4,595 | $42.23 | $194.0K | 0 |
| Feb 22, 2022↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 2,298 | $42.23 | $97.0K | 0 |
| Feb 22, 2022↗ | SARAN ATUL | EVP, Corp Dev, GC & Secretary | Sell | 2,084 | $42.23 | $88.0K | 0 |
| Feb 22, 2022↗ | Strei Katherine | EVP, Chief HR Officer | Sell | 1,616 | $42.23 | $68.2K | 0 |
| May 25, 2021↗ | Zoon Kathryn C | Director | Sell | 3,139 | $56.48 | $177.3K | 0 |
| May 10, 2021↗ | SULLIVAN LOUIS W | Director | Sell | 3,118 | $61.62 | $192.1K | 0 |
| May 8, 2021↗ | Kramer Robert | President and CEO | Sell | 94 | $61.62 | $5.8K | 0 |
| May 8, 2021↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 1,054 | $61.62 | $64.9K | 0 |
| May 7, 2021↗ | Smith Karen L. | EVP, Chief Medical Officer | Sell | 305 | $60.85 | $18.6K | 0 |
| Mar 4, 2021↗ | Bailey Sue | Director | Sell | 8,168 | $92.37 | $754.5K | 0 |
| Mar 1, 2021↗ | Havey Adam | EVP, Business Operations | Sell | 37,279 | $99.30 | $3.70M | 0 |
| Feb 24, 2021↗ | Havey Adam | EVP, Business Operations | Sell | 2,318 | $95.81 | $222.1K | 0 |
| Feb 24, 2021↗ | Kramer Robert | President and CEO | Sell | 5,001 | $95.38 | $477.0K | 0 |
| Feb 24, 2021↗ | LINDAHL RICHARD S | EVP, Chief Financial Officer | Sell | 1,829 | $95.13 | $174.0K | 0 |
| Feb 24, 2021↗ | SARAN ATUL | EVP, Corp Dev, GC & Secretary | Sell | 2,450 | $95.82 | $234.8K | 0 |
| Feb 24, 2021↗ | Strei Katherine | EVP, Chief HR Officer | Sell | 1,829 | $95.91 | $175.4K | 0 |
EBS Insiders
Similar Stocks to EBS
ZTS
Zoetis Inc.
$115.50+0.03%
$50.88B
TEVA
Teva Pharmaceutical Industries Limited
$28.41-3.04%
$36.69B
VTRS
Viatris Inc.
$13.51-1.99%
$15.56B
NBIX
Neurocrine Biosciences, Inc.
$129.78+1.29%
$13.03B
INDV
Indivior Pharmaceuticals Inc
$31.32+1.49%
$4.05B
SUPN
Supernus Pharmaceuticals, Inc.
$49.80-1.30%
$3.08B
PAHC
Phibro Animal Health Corporation
$49.52+1.06%
$1.95B
ANIP
ANI Pharmaceuticals, Inc.
$70.32-3.00%
$1.68B